FY2025 · ended Dec 31, 2025 · Revenue $13.56M, +5.2% YoY · Filed Mar 18, 2026
Hyperfine, Inc. (HYPR) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $13.6 million and a net loss of $35.6 million. Free cash flow was -$29.1 million. As of Jun 30, 2026 it held $43.5 million in cash and investments and $13.4 million in total debt.
Revenue (TTM)
$16.54M
+53.2% vs year-ago TTM
Net income (TTM)
$-34.85M
+11.5% vs year-ago TTM
Operating cash flow (TTM)
$-27.07M
+20.5% vs year-ago TTM
Free cash flow (TTM)
$-27.53M
+21.8% vs year-ago TTM
EPS (TTM)
$-0.38
+28.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
—
Net cash
$30.05M
as of Jun 30, 2026
Operating margin
-203.3%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- HYPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Guilford, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833769
- Former names
- HealthCor Catalio Acquisition Corp. (until Dec 22, 2021)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $13.6M | $12.9M | $11.0M | $6.8M | $1.5M |
| Operating income | -$37.1M | -$43.2M | -$48.1M | -$73.9M | -$64.9M |
| Net income | -$35.6M | -$40.7M | -$44.2M | -$44.2M | -$64.9M |
| Diluted EPS | -$0.43 | -$0.56 | -$0.62 | -$1.04 | — |
| Operating cash flow | -$27.9M | -$38.8M | -$41.8M | -$72.3M | -$47.2M |
| Free cash flow | -$29.1M | -$39.1M | -$42.6M | -$72.9M | -$49.9M |
| Total assets | $55.3M | $58.9M | $94.2M | $134.1M | $202.5M |
| Total liabilities | $14.3M | $9.9M | $9.8M | $10.3M | $16.2M |
| Stockholders' equity | $41.0M | $49.0M | $84.4M | $123.7M | $186.2M |
| Cash and investments | $35.1M | $37.6M | $75.2M | $117.5M | $188.5M |
| Total debt | $314,000 | $347,000 | $249,000 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 8, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 18, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
All 367 Hyperfine, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.